Table Of ContentINDEX, the journal of Pharmacy Technology
VOLUME Twenty-three — JANUARY THROUGH DECEMBER 2007
January/February Pages 1-64 July/August Pages 197-260
March/April Pages 65-132 September/October Pages 261--324
May/June Pages 133-196 November/December Pages 325-394
Amantadine, traumatic brain injury (A), 95 Ballard, Catherine L (author), book review,
A-C American Pharmacists Association, concerns 188; (author), book review, 313
regarding tamper-resistant pad requirement Bar codes, online problem reports to ASHP
Ablah, Elizabeth (coauthor), see Fromer, for MEDICAID (POR), 306; practice guide- recommended (PF), 181
Deborah B, 75 lines regarding influenza pandemic (POR), Barrett’s esophagus, associated with adeno-
ACAM2000, smallpox vaccine, approved by 306; vaccination bulletin available for prac- carcinoma (CN), 299
FDA (NP), 303 tice guidelines regarding influenza pan- Beauchesne, Marie-France (author), Active
Acrylaway, see asparaginase demic (POR), 307 Communication of a Pharmacy Discharge
Acute coronary syndrome, benefit of enoxa- American Society of Health-System Pharma- Plan for Patients with Respiratory Diseases:
parin (TT), 357 cists, future issues addressed (PF), 249; on- A Pilot Study (A), 67
Acute lymphoblastic leukemia, resistance to line resource center available (POR), 377; Bell, Edward A (author), book review, 253
imatinib (CN), 368 patient consultation encouraged (POR), 307; Benign prostatic hypertrophy, dutasteride
Adalimumab, effective in juvenile rheuma- practice guidelines regarding influenza plus tamsulosin effective (TT), 363
toid arthritis (TT), 174 pandemic (POR), 306; publishes new vac- Bevacizumab, with chemotherapy, effective in
Adefovir, compared with entecavir, hepatitis cine bulletin (POR), 307; supports Senate's lung cancer (TT), 110
B (TT), 237 drug safety legislation (PF), 247; task force Black, Stephanie (coauthor), see Patel,
Adenocarcinoma, associated with Barrett's addresses diverse workforce (PF), 249 Gourang P, 79
esophagus (CN), 299 Anderson, Howard C Jr (coauthor), see Peter- Blais, Lucie (coauthor), see Beauchesne,
Adherence, electronic reminder system avail- son, Charles D, 158 Marie-France, 67
able (NP), 375 Androstenedione, effects of supplementation Books received, 59, 124, 189, 256, 316, 384
Adolescent girls, increased use of prescription on serum gonadal hormones (A), 349 Bérjesson, Inger (coauthor), see Teng, Renli,
drugs (WN), 243 Anthracycline, dexrazoxane approved to treat 270
Advair, 500/50 formulation effective in chron- extravasation (CN), 371 Brain cancer, DCVax-Brain vaccine available
ic obstructive pulmonary disease (TT), 111 Anticoagulants, computer-assisted dosage in Switzerland (NP), 304
African Americans, poor nutrition shown calculation (TT), 289 Breast cancer, aromatase inhibitors improve
(WN), 114 Aripiprazole, effective in bipolar disorder survival (TT), 294; chemotherapy more ef-
Akabane, Michiya (author), Long-Term (TT), 45 fective before surgery (TT), 238; ixabepilone
Glycemic Control After a One Week Hospi- Aromatase inhibitors, early switch from ta- approved (CN) 371
tal Education Program for Inpatients with moxifen effective in breast cancer 110; im- Bronchiectasis, mannitol dry inhalation pow-
Type 2 Diabetes (A), 263 proved survival in breast cancer (TT), 294 der effective (TT), 362
Albrecht, Linda S (author), book review, 189; Asparaginase, new product available (NP), Brouse, Sara D (coauthor), see Mullin, Molly
(author), book review, 312 302 A,3
Alemtuzumab, superior to chlorambucil (TT), Assemi, Mitra (coauthor), see Jariangprasert, Budesonide, with formoterol, effective in
43 Chad S, 214 asthma (TT), 173
Aliskiren, inferior to other antihypertensives Asthma, corticosteroid inhaler not requiring Burkiewicz, Jill S (coauthor), see Fit, Kathy E,
(WN), 177 hand / breath coordination available (WN), 9; (coauthor), see Ryzner, Kristi L, 199
Aluminum hydroxide adsorbed insect venom 244 Bush, Marsha L (coauthor), see Ghivizzani,
extracts, reduces incidence of asthma (TT), Attention deficit/hyperactivity disorder, lis- Steven C, 86
295 dexamfetamine approved (WN), 114; Cairns, Chris J (author), book review, 55
Alutard SQ, see aluminum hydroxide ad- methylphenidate improves performance Calcium supplement, new formulation avail-
sorbed insect venom extracts (TT), 295 able for women (WN), 177; with vitamin D,
Alzheimer’s disease, Mild Cognitive Impair- Axitinib, effective in advanced thyroid cancer prevents weight gain in postmenopausal
ment Screen effect in early detection (CN), (TT), 238 women (TT), 240
300; no significant benefit of tramiprosate Baldwin, H John (coauthor), see Droege, Calendar of Events, 53, 119, 185, 251, 308, 379
(TT), 361 Marcus, 142 Candesartan cilexetil, bioavailability (A), 270
WWW.)JPHARMTECHNOL.COM Novemser/Decemser 2007 @ Vo.me 23 @ J PHARMTECHNOL 389
Capecitabine, with oxaliplatin, equivalent to Cruz, Martin (coauthor), see Nieves, JE dwin, Escitalopram, economic evaluation (A), 35;
FOLFOX-4 (TT), 44 281 superior to duloxetine (TT), 45
Cappuzzo, Kimberly A (author), book review, Cyclosporine, effective in keratoconjunctivitis Etanercept, improves moderate-to-severe nail
187 (TT), 239 psoriasis (TT), 171
Capsaicin, synthetic formulation effective in Fentanyl, buccal tablets, effective in opioid-
postherpetic neuralgia (TT), 362 D-F tolerant patients (TT), 288; intranasal, effec-
Carpal tunnel syndrome, exercises available tive in cancer pain (TT), 288
through Web site (NP), 304 Fexofenadine, effective for allergy in children
Ceftobiprole, effective in methicillin-resistant D-Cycloserine, effective in obsessive-compul- (WN), 175
Staphylococcus aureus (TT), 359 sive disorder (CN), 300; effective in smok- Fillion, Anne (coauthor), see Beauchesne,
Celecoxib, effective in premature neonates (TT), ing cessation (CN), 300 Marie-France, 67
237 Dabigatran etexilate, effective in risk reduc- Fit, Kathy E (author), PDA-Based Documen-
CellCept, see mycophenolate mofetil tion of thromboembolism following total tation of Medication Interventions in an
Certolizumab pegol, effective in rheumatoid hip replacement (TT), 290 Ambulatory Care Setting (A), 9
arthritis (TT), 240 Daniel, Karen L (coauthor), see Droege, Mar- Flaxseed, effective in hot flashes (TT), 364
Cetuximab, lengthened survival rates (TT), 44; cus, 142 Fluticasone, nasal spray effective in allergy
supplemental biologics application reviewed Darley, William K (coauthor), see Holiday- symptoms (WN), 175
by FDA (WN), 242 Goodman, Monica, 16 FOLFOX-4, equivalent to capecitabine/ o xali-
Chemotherapy, adverse effects evaluated Darunavir, with ritonavir, achieves reduced platin (TT), 44
with hand-held computer (CN), 369; in- viral load (TT), 291 Folic acid, prophylaxis of cleft lip and palate
creased effectiveness before breast cancer Deshmukh-Estoll, Harsha C (coauthor), see (TT), 43
surgery (TT), 238; with bevacizumab, effec- Holiday-Goodman, Monica, 16 Food and Drug Administration, ACAM2000
tive in lung cancer (TT), 110 Dexrazoxane, approved to treat anthracycline approved (NP), 303; droperidol warning
Chen Julie L (author) Poor Central Nervous unnecessary (TT), 363; cetuximab, supple-
extravasation (CN), 371
System Penetration of Tigecycline in a Pa- mental application reviewed (WN), 243;
Diabetes, barriers to pharmacists’ provision
tient with Sepsis and Ventriculitis Caused Drug Safety Newsletter launched (NP), 375;
of care (A), 327; selenium supplements in-
by Multidrug-Resistant Klebsiella pneumoni- enoxaparin, new indication approved (TT),
crease risk (CN), 297
ae, 344 171; lisdexamfetamine approved (WN), 114;
Chesnut, RenaeJ (coauthor), see Plake, Kim- Diabetes, type 2, glycemic control after hospi- marketing of unapproved hydrocodone
berly S, 327 tal education (A), 263; pharmacist consulta- products halted (CN), 373; Menactra
Chlorambucil, inferior to alemtuzumab (TT), tion (CN), 298 meningococcal vaccine approved (NP), 368;
43 Dinh, Thanh-Ha (coauthor), see Beauchesne, potency specifications for levothyroxine
Cholesterol test, to assess risk of cardiovascu- Marie-France, 67 sodium (CN), 371; proposed elimination of
lar disease (WN), 241 Do, Thy (coauthor), see Velentgas, Priscilla, 221 chlorofluorocarbons from epinephrine in-
Chronic obstructive pulmonary disease, Dockter, Tanya L (author), book review, 381 halers (CN), 367; public access to data re-
500/50 formulation effective (TT), 111; neb- Doripenem, effective in hospital-acquired quested (WN), 175; recommends against
ulized formoterol fumarate effective (TT), pneumonia (TT), 359 online purchase of isotretinoin (PF), 182;
239 Doxorubicin, liposomal formulation effective West Nile virus testing approved (NP), 303
Chung, LY (coauthor), see Noordin, Mo- in recurrent ovarian cancer (TT), 110 Formoterol, nebulized, effective in chronic ob-
hamed Ibrahim, 339 Droege, Marcus (author), Consumers’ Risk structive pulmonary disease (TT), 239; with
Cisneros, Robert M (author), book review, 254 Perceptions of Prescription and Over-the- budesonide, effective in asthma (TT), 173
Cisplatin, biomarker predicts response in Counter Medications (A), 142 Forster, Keith (coauthor), see Welch, Justin
lung cancer (TT), 294 Droperidol, FDA warning unnecessary (TT), M, 104
Citalopram, response predicted by gene vari- 363 From the Literature, 48, 115, 178
ation (CN), 300 Drug labeling, misunderstanding evaluated From the States, 52, 184
Citrome, Leslie L (author), book review, 123 (PF), 50 Fromer, Deborah B (author), Pharmacists’
Clinical News, 297, 367 Drug safety, rate of monitoring evaluated Self-Assessments Regarding Emergency
Clinical trials, excessive cost (PF), 50 (PF), 181 Preparedness Activities in Kansas (A), 75
Clostridium difficile, tolevamer not effective Duloxetine, less effective than escitalopram
in associated diarrhea (TT), 291 (TT), 45 G-I
Common cold, zinc lozenges ineffective (TT), Dutasteride, with tamsulosin, effective in be-
292 nign prostatic hypertrophy (TT), 363
Compounding, FDA warnings (FL), 178; leg- Dyslipidemia, persistence (A), 221 Gabapentin, dose adjustment (A), 30
islation (PF), 180 Galioto, Nicholas J (coauthor), see Trewet,
Computers, evaluation of chemotherapy ad- EEla-tIibniga ryh,a biSthsa,r eWeenb Ys i(tec oeaduutchoart)i,o ns e(e WJNa)r,i an1g1-4 CoraLynn B, 166
verse effects (CN), 369; prescription writing Genetics, increased bacterial resistance (TT),
software beneficial (PF), 182 prasert, Chad S, 214 360; testing evaluated (PF), 50
Congestive heart failure, KW-3902 effective Eltrombopag olamine, effective in idiopathic Ghivizzani, Steven C (author), Interleukin-1
(TT), 233 thrombocytopenia (TT), 235 in Rheumatoid Arthritis: Its Inhibition by
Emergency preparedness, pharmacists’ self-
Constipation, diminished quality of life (CN), IL-1Ra and Anakinra (A), 86
367 assessments (A), 75 Glaucoma, persistence (A), 221
Enoxaparin, approved for use in acute ST-seg- Gonyeau, Michael J (author), Should
Consumers, choice of drug provider (A), 16;
drug disposal (PF), 118; perception of risk ment elevation myocardial infarction (TT), Gabapentin Be Dose Adjusted: What Are
associated with drugs (A), 142 171; benefit in acute coronary syndrome the Clinical Consequences? (A), 30
Cook, David J (coauthor), see Fromer, Debo- (TT), 357; long-term prophylaxis of throm- Gouz, Jean-Noel (coauthor), see Ghivizzani,
rah B, 75 boembolism effective (TT), 290; reduced in- Steven C, 86
Corticosteroids, inhaler not requiring hand / cidence of thromboembolism (TT), 109 Gouze, Elvire (coauthor), see Ghivizzani,
breath coordination available (WN), 244 Entecavir, compared with adefovir, hepatitis Steven C, 86
Cranberry juice, elevated international nor- B (TT), 237 Halvorson, Diane (coauthor), see Scott,
malized ratio (A), 104 Epinephrine inhalers, elimination of chlo- David M, 148
Crank, Christopher W (coauthor), see Patel, rofluorocarbons (CN), 367 Hand-washing, video used for hospital visi-
Gourang P, 79 Erlotinib, effective in pancreatic cancer (TT), 172 tors (WN), 242
Creatine, use in Parkinson's disease investi- Ernst, Michael E (coauthor), see Weber, Hansson, Anna-Carin (coauthor), see Teng,
gated (WN), 176 Cynthia A, 349 Renli, 270
390 = J. Paro TecHNot & Vowwme2 3 Novemser/Decemser 2007
Headache, cluster, zolmitriptan nasal spray ef- Kay, Jesse D (coauthor), see Ghivizzani, Metabolic syndrome, linked to cardiovascu-
fective (TT), 362 Steven C, 86 lar disease (WN), 47
Heart failure, prescription frequency (A), 199 Kehoe, William A (author), book review, 254 Methicillin-resistant Staphylococcus aureus,
Hepatitis B, adefovir effective (TT), 237; ente- Keratoconjunctivitis, cyclosporine effective ceftobiprole effective (TT), 359; increased in-
cavir effective (TT), 237 (TT), 239 cidence (WN), 241
Herman, Ronald (author), book review, 381 Kerr, Jessica L (author), Varenicline: A Novel Methylphenidate, improves performance in
High-density lipoprotein cholesterol, possi- Nicotinic Receptor Partial Agonist for attention deficit /h yperactivity children
ble dysfunction type (CN), 298 Smoking Cessation (A), 23 with sleep deficiency (TT), 294
Historical quote, Foreign and American Tech- Ketoconazole, compounding (CF), 309 Metoprolol, compounding (CF), 186
nicians, 324 Killu, Claude (coauthor), see Chen Julie L, Minocycline, rapid treatment effective in
Holiday-Goodman, Monica (author), Investi- 344 stroke (TT), 360
gation of Consumer Choice of Community, Klebsiella pneumoniae, multidrug resistant, Mittmann, Nicole (coauthor), see Sadri,
Mail Order, or Internet Pharmacies (A), 16 poor central nervous system penetration of Hamid, 35
Hormone therapy, postmenopausal, revised tigecycline (A), 344 Molgaard, Craig A (coauthor), see Fromer,
prescribing guidelines available (WN), 244 Konishi, Hiroki (coauthor), see Akabane, Deborah B, 75
Hot flashes, flaxseed effective (TT), 364 Michiya, 263 Mullin, Molly A (author), A Comparison of
Hydrocodone, marketing of unapproved Kerth-Bradley, JM (author), book review, 255 Event Rates for Patients Receiving,
products halted (CN), 373 Kuti, Joseph L (coauthor), see Sahni, Jasmine Sirolimus Drug-Eluting vs. Bare Metal
Hypertension therapy, combination vs mono- K, 203 Stents (A), 3
therapy (TT), 233; effective in obese and non- KW-3902, effective in congestive heart failure Multiple sclerosis, benign diagnosis probably
obese patients (TT), 233; olmesartan effec- (TT), 233 incorrect (WN), 113; interferon beta-1b, de-
tive in stage 2 (TT), 236; persistence (A), 221 Labetalol, compounding (CF), 186 lays progression (TT), 293
Iclaprim, effective in skin and skin structure Labrecque, Manon (coauthor), see Beau- Murty, Sharanya (author), Consumer Com-
prehension of OTC Medication Labels and
infections (TT), 292 chesne, Marie-France, 67
Idiopathic thrombocytopenia, eltrombopag Lamotrigine, compounding (CF), 309 the Scope for Improvement in Font Size (A),
olamine effective (TT), 235 Lansoprazole, compounding (CF), 380 207
Mycophenolate mofetil, effective in lupus
Imatinib, high 5 year survival rate (TT), 45; re- Leukopenia, associated with paroxetine (A),
nephritis (TT), 295
sistance in acute lymphoblastic leukemia 166 Myocardial infarction, increased risk with
(CN), 368 Levings, Padraic P (coauthor), see Ghivizzani, rosiglitazone (TT), 358; lower risk with pi-
Influenza, cross-protection against H5N1 pos- Steven C, 86 oglitazone (TT), 358
sible with yearly vaccination (WN), 113; Levodopa/carbidopa, compounding (CF), 380 National Association of Chain Drug Stores,
nasal spray vaccine effective in children Levothyroxine sodium, potency specifica- practice guidelines regarding influenza
(WN), 112; pre-pandemic vaccine under in- tions (CN), 371 pandemic (POR), 306
vestigation (WN), 112; practice guidelines Linaclotide, effective in irritable bowel syn- National Pharmacy Technician Day, an-
regarding pandemic available (POR), 306; drome (TT), 235 nouncement, ibc-] / A, ibe-S/O; training
therapeutic interventions (A), 79 Lisdexamfetamine, approved for marketing program listing, 321
Insomnia, ramelteon effective (TT), 361 (WN), 114 Natural health products, pharmacist counsel-
Insulin, digital pen with memory available Lisinopril, compounding (CF), 120 ing (CN), 297
(WN), 112; standard sliding scale order (A), Lively, Buford T (coauthor), see Holiday- Nebivolol, combination vs monotherapy
135 Goodman, Monica, 16 (TT), 233; treatment of obese vs nonobese
Interferon beta-1b, delays progression of Lubiprostone, effective in irritable bowel syn- patients (TT), 233
multiple sclerosis (TT), 293 drome (TT), 235; investigated in renal and Nenciu, Laura M (coauthor), see Beauchesne,
Interleukin-1, rheumatoid arthritis (A), 86 hepatic impairment (TT), 172 Marie-France, 67
Internet, consumer drug purchase dangerous Lung cancer, biomarker predicts response to Neville, Judith L (author), book review, 383;
(CN), 299; exercises for carpal tunnel syn- cisplatin (TT), 294 (author), book review, 384
drome available (NP), 304; pharmacy con- Lupus nephritis, mycophenolate mofetil ef- New Products, 302, 375
sultation, women’s questions (A), 214; phar- fective (TT), 295 New Publications, Ast/ima in Focus, 311; Basic
macy director's site available (PF), 247; Pharmacokinetics, 381; Basics of Aseptic Com-
physician news with “The Doctor’s Chan- pounding Technique Video Training Program,
nel” (NP), 302 M-N 123; Essentials of Law and Ethics for Pharmacy
Iowa, barriers to pharmacist provision of dia- Technicians, 2nd edition, 384; Handbooofk In -
betes care (A), 327 Maniscalco, Maria (coauthor), see Droege, stitutional Pharmacy Practice, 4th ed., 55;
Irritable bowel syndrome, linaclotide effec- Marcus, 142 Health Care Informatics: A Skills-Based Re-
tive (TT), 235; lubiprostone effective (TT), Mannitol, dry inhalation effective in source, 123; Miracle Medicines: Seven Lifesav-
235 bronchiectasis (TT), 362 ing Drugs and the People Who Created Them,
Isoniazid, compounding (CF), 252 Medical records, tracking software available 255; Mosby's Pharmacy Technician Lab Manual,
Isotretinoin, FDA recommends against online (PF), 181 315; Mosby's Pharmacy Technician Principles
purchase (PF), 182 Medicare Part D, most common drugs cov- and Practice, 2nd edition, 381; Paediatric Drug
Isradipine, compounding (CF), 252 ered (PF), 248 Handling, 253; Patient Care Management Lab:
Ixabepilone, approved for advanced breast Medication errors, common causes (CN), 370; A Workbook for Prescription Practice, 2nd edi-
cancer (CN), 371 elements of prescribing process (CN), 369; tion, 312; Pharmaceutical Calculations for the
tech-check-check regulation (FS), 52 Pharmacy Technician, 313; Pharmaceutical Cal-
Medication labels, improved font size (A), 207 culationfso r Pharmacy Technicians: A Worktext,
J-L
Meniere's disease, nonsurgical treatment ef- 56; Pharmaceutical Compounding and Dispens-
fective (WN), 113 ing, 121; Pharmacy Law: Desk Reference, 189;
Jariangprasert, Chad S (author), What Wom- Meningococcal vaccine, Menactra formula- Pharmacy Practice in an Aging Society, 187;
en Want to Know: An Assessment of On- tion approved (CN), 368 Pharmacy Technician Certification Quick-Study
line Questions Asked by Women Using an Mental health, telepharmacy management Guide, 3rd edition, 188; Pharmacy: What It Is
Ask-the-Pharmacist Service (A), 214 (A), 281 and How It Works, 2nd edition, 254; Pocket
Johnson, Eric (coauthor), see Velentgas, Mentor, Sherry M (coauthor), see Velentgas, Guide for Pharmacy Technicians, 312; The
Priscilla, 221 Priscilla, 221 Handbook on Storing and Securing Medications,
Karpinski, Julie P (coauthor), see Kerr, Jessi- Mesalamine, long-term therapy, effective in 56; The Pharmacy Technician, 383; The Pharma-
ca L, 23 ulcerative colitis (TT), 234 cy Technician Skills-Building Manual, 254
WWW.jJPHARMTECHNOL.COM Novemser/Decemser 2007 @ Vowme 23 @ J PHARMTECHNOL 391
NGX-4010, effective in postherpetic neuralgia management (CN), 298; Internet, women’s Satraplatin, effective in prostate cancer (WN),
(TT), 293 questions (A), 214; natural health products 176
Nicolau, David P (coauthor), see Sahni, Jas- (CN), 297; patients encouraged to request in- Schrater, Suzanne R (coauthor), see Fromer,
mine K, 203 formation (POR), 307 Deborah B, 75
Nicotine, initial dose associated with addic- Pharmacy Focus, 50, 118, 180, 247 Scott, David M (author), Assessment of Phar-
tion (CN), 372 Pharmacy Organization Reports, 306, 377 macy Technicians’ Salary, Benefits, and Re-
Nieves, J Edwin (author), Telepharmacy in Pharmacy Technician Certification Board, sponsibilities in North Dakota (A), 148
Mental Health Outpatient Case Manage- electronic examination initiated (PF), 50 Seeger John D (coauthor), see Velentgas,
ment (A), 281 Pharmacy Technician Educators Council, An- Priscilla, 221
Nishio, Yoshihiko (coauthor), see Akabane, nual Meeting Report, 285 Selenium, supplements increase risk of dia-
Michiya, 263 Pharmacy technicians, certification program betes (CN), 297
Noordin, Mohamed Ibrahim (author), Ro- accredited (PF), 118; minimum age recom- Sheffield, Reinee (coauthor), see Velentgas,
bustness of Palm Kernel Oil Blend in Sup- mendation (FS), 184; number certified (PF), Priscilla, 221
pository Preparation Using Acetaminophen 50; practice in North Dakota (A), 148; recon- Siganga, Walter (coauthor), see Holiday-
as Model Drug (A), 339 stitution time (A), 203 Goodman, Monica, 16
Nordstrom, Beth L (coauthor), see Velentgas, Pill-splitting, cost reduction (PF), 248 Sirolimus, drug-eluting vs. bare metal stents
Priscilla, 221 Pioglitazone, lower risk of myocardial infare- (A), 3; significantly lower risk of clotting
tion (TT), 358 (TT), 357
Piperacillin/tazobactam, reconstitution (A), 203 Skin and skin structure infections, iclaprim
O-R
Plake, Kimberly S (author), Barriers to Com- effective (TT), 292
munity Pharmacists’ Provision of Diabetes Skwiera, John (coauthor), see Peterson,
Obsessive-compulsive disorder, D-cycloserine Care Services in lowa (A), 327 Charles D, 158
effective (CN), 300 Pneumonia, hospital-acquired, doripenem ef- Smallpox vaccine, ACAM2000 approved
Odorzynski, Melissa (coauthor), see Plake, fective (TT), 359 (NP), 303; fever genetically related (TT), 236
Kimberly S, 327 Postherpetic neuralgia, dermal patch effective Smoking cessation, D-cycloserine effective
Olmesartan, effective in stage 2 hypertension (TT), 293; synthetic formulation of capsaicin (CN), 300
(TT), 236 effective (TT), 362 Sorafenib, effective in advanced liver cancer
Opioids, mechanism explained with critical Postmenopausal osteoporosis, risedronate (TT), 111
pain pathway (TT), 110 once monthly effective (TT), 364 Sotalol, compounding (CF), 120
Orsini, Jose (coauthor), see Chen Julie L, 344 Prescribing, basic elements (CN), 369; electron- Stack, Kathleen M (coauthor), see Nieves, J
Orum-Alexander, Gail (author), book review, ic, reduced errors (PF), 118; off-label, used in Edwin, 281
56; (author), book review, 312 most hospitalized children (PF), 180; off-la- Steroids, safety shown in premature infants
Osteocalcin, controls glucose regulation and bel, risks /b enefits unclear to patients (PF), 51 (TT), 172
fat deposition (CN), 298 Proton pump inhibitors, risk of hip fracture Stroke, rapid minocycline treatment effective
Over-the-counter drugs, consumer compre- (A), 275 (TT), 360
hension of labels (A), 207; safe use outreach Psoriasis, new treatments investigated (WN), Stuhan, Mary Ann (author), book review, 315;
program conducted (FL), 48 112 (author), Reenergize Your Educational En-
Oxaliplatin, 200 mg vial available (NP), 376; Ramelteon, effective in insomnia (TT), 361 gines: 2007 PTEC Annual Meeting Report
with capecitabine, equivalent to FOLFOX-4 Rathke, Ann (coauthor), see Peterson, Charles (PTEC News), 285
(TT), 44 D, 158 Sweeney, Brooke L (coauthor), see Fit, Kathy
Ray, Shaunta’ M (author), book review, 311
Pain. critical pathway explained (TT), 110 E,9
Paliperidone, effective in schizophrenia (TT), Respiratory diseases, discharge plan (A), 67 Tahir, Rabia (author), Role of Proton Pump
Rheumatoid arthritis, certolizumab pegol ef-
173 Inhibitors in Calcium Absorption, Bone Re-
fective (TT), 240; interleukin-1 (A), 86
Palm kernel oil, with theobroma oil, supposi- sorption, and Risk of Hip Fracture (A), 275
Rios, Joanne M (author), book review, 56; (au-
tory formulation (A), 339 thor), book review, 121 Tamoxifen, discontinuation rates high (WN),
Pappas, Jeannie (author), book review, 123 47; early switch to aromatase inhibitor effec-
Risedronate, once monthly dosing effective in
Patel, GourPa (anuthgor ), Therapeutic Inter- tive in breast cancer, 110
postmenopausal osteoporosis (TT), 364
ventions for the Treatment and Control of In- Tamsulosin, with dutasteride, effective in be-
Ritonavir, with darunavir, achieves reduced vi-
fluenza (A), 79 nign prostatic hypertrophy (TT), 363
ral load (TT), 291
Patel, Priti N (coauthor), see Tahir, Rabia, 275 Tassé, Michel (coauthor), see Beauchesne,
Rooney, Christina A (coauthor), see Gonyeau,
Patient education, motivation interviewing Michael J, 30 Marie-France, 67
training available (PF), 183; rate evaluated Rosiglitazone, increased risk of myocardial in- Telepharmacy, mental health management
(PF), 181 (A), 281; service to rural hospitals (A), 158
farction (TT), 358
Patient history, digital pen system available Rotavirus, vaccine not associated with intus- Teng, Renli (author), Oral Bioavailability of
(NP), 304 susception (WN), 176 Candesartan Cilexetil Suspension (A), 270
Payne, Thomas J (coauthor), see Trewet, Cora- Test Your Knowledge, answers, 64, 132, 196,
Ryzner, Kristi L (author), Retrospective Evalu-
Lynn B, 166 ation of Prescription Frequency in Heart Fail- 260, 320, 388; questions, 2, 66, 134, 198, 262,
Pediatrics, adolescents, initial nicotine dose as- ure (A), 199 326
sociated with addiction (CN), 372; infants, Theobroma oil, with palm kernel oil, suppos-
pharmacist consultation regarding cough itory formulation (A), 339
and cold products encouraged (POR), 377; S-Z Therapeutic Trends, 43, 109, 171, 233, 288, 357
young children, increased prescribing for Thyroid cancer, axitinib effective (TT), 238
gastrointestinal disorders (CN), 372 Sadri, Hamid (author), A Qualitative Review Tiagabine, compounding (CF), 54
Persistence, therapy for glaucoma, hyperten- of Recent Economic Evaluations of Escitalo- Tigecycline, poor central nervous system pen-
sion, dyslipidemia (A), 221 pram (A), 35 etration in patient with multidrug-resistant
Personal digital assistant, beneficial in ambu- Sahni, Jasmine K (author), Time Required by Klebsiella pneumoniae (A), 344
latory care (A), 9 Pharmacy Technicians to Reconstitute New Timpe, Erin M (coauthor), see Kerr, Jessica L,
Peterson, Charles D (author), Hospital Tele- versus Old Piperacillin /T azobactam For- 23
pharmacy Network: Delivering Pharmacy mulations (A), 203 Tolevamer, not effective in Clostridium difficile-
Services to Rural Hospitals (A), 158 Sansgiry, Sujit S (coauthor), see Murty, Sha- associated diarrhea (TT), 291
PharmaCF test, 61, 127, 193, 257, 317, 387 ranya, 207 Topiramate, compounding (CF), 54
Pharmacist consultation, diabetes care ser- Saran, Jeetpaul (coauthor), see Ghivizzani, Tramiprosate, no significant benefit in
vices, barriers in lowa (A), 327; diabetes Steven C, 86 Alzheimer’s disease (TT), 361
392 =| PHarm TecHNot @ Vowwme 23 of Novemser/Decemper 2007 WWW. )JPHARMTECHNOL.COM
Treprostinil, inhaled formulation effective (TT), Welch, Justin M (author), Probable Elevation
109; rapid switch improves long-term out- in International Normalized Ratio from Index Abbreviations
come (TT), 109 Cranberry Juice (A), 104
Trewet, CoraLynn B (author), Leukopenia As- West Nile virus, test approved (NP), 303
sociated with Paroxetine Use (A), 166 What's New, 47, 112, 175, 241 Article
Tsourounis, Candy (coauthor), see Jariang- Wilbur, Kerry (author), Evaluation of a Stan- Compounding Formulations
prasert, Chad S, 214 dardized Sliding Scale Insulin Preprinted
Ulcerative colitis, long-term mesalamine ef- Order (A), 135 Clinical News
fective (TT), 234 Women, questions asked online (A), 214 From the Literature
USP 797, white paper addressing compound- Wood, Heidi M (coauthor), see Weber, Cyn-
ing available (PF), 249 thia A, 349 Guest Editorial
Vaccination, ACAM2000 approved (NP), 303; Yamaji, Akira (coauthor), see Akabane,
Inside back cover
bulletin available for pharmacists (POR), Michiya, 263
307; DC Vax for brain cancer available in Yu, Christine (coauthor), see Wilbur, Kerry, 135 Inside front cover
Switzerland (NP), 304; schedules and rec- Zinc, lozenges ineffective for common cold New Preducts
ommendations {FL), 115; smallpox, fever (TT), 292
genetically related (TT), 236 Zolmitriptan, nasal spray effective in cluster Pharmacy Focus
Valacyclovir, reduction of both HIV and her- headache (TT), 362 Pharmacy Organization Reports
pes simplex virus shown (WN), 113
Varenicline, use in smoking cessation (A), 23 Therapeutic Trends
Advertisers
Velentgas, Priscilla (author), Persistence with What’s New
Medications in Glaucoma Management,
Hypertension, and Dyslipidemia (A), 221 American Association of Pharmacy Techni-
Venous thromboembolism, risk (TT), 289 cians, convention, 125, 183; membership, Statement of ownership, management, and monthly cir-
Vildagliptin, efficacy, tolerability reinforced 51, 74, 179, 220, 283, 338 culation (6 issues, $181.00 annualiy) of the journal of
(TT), 43 Certification Review for Pharmacy Techni- PHharavremya cyW hiTtencehyn oloBgoyo,k s puCbolimcpaatniyo.n Pnou.b li8s7h5e5r-:1 22H5a.r vOewyn erA,K
Villareal, Carolyn L (author), Amantadine cians, 7th edition, 131, ibc-] /F , ibc-M/J; 8th Whitney Jr. Headquarters of publisher, owner, and publi-
Therapy in Traumatic Brain Injury Patients edition, ibc-N /D cation: 8044 Montgomery Road, PO Box 42696, Cincin-
(A), 95 journal of Pharmacy Technology, subscrip- nati, OH 45242. Known bondholders, mortgages, and
Vitamin D, deficiency linked to hip fracture tion, 41, 110, 169, 232, 284, 356 other security holders: none. Average no. of copies of
(CN), 373; reduces falls in nursing home Medical Abbreviations, 46, 168, 250, 296, 374 each issue from October 2006 to October 2007 and no. of
copies of November /D ecember 2006 to September /Oc-
residents (TT), 110; with calcium, prevents Pediatric Drug Formulations, 5th edition, 63, tober 2007 issue: a. total no. copies printed (net press
weight gain in postmenopausal women 170, ibc-M / A, 310, 366 run) 550, 550; b. paid and /o r requested circulation (1)
(TT), 240 Pharmacoepidemiology, 3rd edition, 42, 195 paid or requested mail subscriptions 292, 304; c. total
Vitamins, new formulation available for Pharmacy Technician Educators Council, an- paid and /o r requested circulation 346, 368; d. free distri-
women (WN), 177 nual meeting, 107; membership, 191, 231, bution by mail 57, 56; e. total free distribution 57, 56; f. to-
tal distribution 403, 424; g. copies not distributed 147,
Watson, Rachael S (coauthor), see Ghivizzani, 274, 365 126; h. total 550, 550. No. of issues published annually: 6
Steven C, 86 Therapeutics in the Elderly, 3rd edition, 126, Date of filing 1 October 2007. Signed: Ann Brandewiede.
Weber, Cynthia A (author), The Effects of An- 394 Circulation Manager.
drostenedione Supplementation on Serum
Gonadal Hormones (A), 349
WWW. JPHARMTECHNOL.COM Novemser/December 2007 mw Vowwme 23 @ J PHARM TECHNOL 393
